2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine

C196H443N31 — CID 161131089

IUPAC2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine
SMILESC.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.CC(C)N1CCC2(C1)CN(C(C)C)C2.CC(C)N1CCCN(C(C)C)CC1.CC(C)N1CCCN(C(C)C)CCC1.CC(C)N1CCCN(C(C)C)[C@H](C)C1.CC(C)N1CCN(C(C)C)C(C)(C)C1.CC(C)N1CCN(C(C)C)CC1.CC(C)N1CCN(C(C)C)[C@@H](C)C1.CC(C)N1CCN(C(C)C)[C@H](C#N)C1.CC(C)N1CCN(C(C)C)[C@H](C)C1.CC(C)N1CC[C@@H](C)N(C(C)C)CC1.CC(C)N1C[C@@H]2CN(C(C)C)[C@@H]2C1.CC(C)N1C[C@@H]2C[C@H]1CN2C(C)C.CC(C)N1C[C@H]2CC[C@@H](C1)N2C(C)C.CC(C)[C@@H]1CCN(C(C)C)C1.CC(C)[C@H]1CCN(C(C)C)C1.CC[C@@H]1CN(C(C)C)CCN1C(C)C
InChIInChI=1S/2C12H24N2.5C12H26N2.C11H21N3.2C11H22N2.3C11H24N2.C10H22N2.2C10H21N.16CH4/c1-10(2)13-6-5-12(7-13)8-14(9-12)11(3)4;1-9(2)13-7-11-5-6-12(8-13)14(11)10(3)4;1-10(2)13-7-8-14(11(3)4)12(5,6)9-13;1-10(2)13-7-6-12(5)14(9-8-13)11(3)4;1-10(2)13-7-6-8-14(11(3)4)12(5)9-13;1-11(2)13-7-5-9-14(12(3)4)10-6-8-13;1-6-12-9-13(10(2)3)7-8-14(12)11(4)5;1-9(2)13-5-6-14(10(3)4)11(7-12)8-13;1-8(2)12-6-11-5-10(12)7-13(11)9(3)4;1-8(2)12-5-10-6-13(9(3)4)11(10)7-12;2*1-9(2)12-6-7-13(10(3)4)11(5)8-12;1-10(2)12-6-5-7-13(9-8-12)11(3)4;1-9(2)11-5-7-12(8-6-11)10(3)4;2*1-8(2)10-5-6-11(7-10)9(3)4;;;;;;;;;;;;;;;;/h10-11H,5-9H2,1-4H3;9-12H,5-8H2,1-4H3;10-11H,7-9H2,1-6H3;2*10-12H,6-9H2,1-5H3;11-12H,5-10H2,1-4H3;10-12H,6-9H2,1-5H3;9-11H,5-6,8H2,1-4H3;2*8-11H,5-7H2,1-4H3;2*9-11H,6-8H2,1-5H3;10-11H,5-9H2,1-4H3;9-10H,5-8H2,1-4H3;2*8-10H,5-7H2,1-4H3;16*1H4/t;11-,12+;;2*12-;;12-;11-;2*10-,11-;2*11-;;;2*10-;;;;;;;;;;;;;;;;/m...11.110110..10................/s1
InChIKeyUMERUSWJVYOHLH-VRVKEMGDSA-N
MW3234.92 g/mol
LogP40.83
Rot. Bonds33

About 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine

2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine (PubChem CID 161131089) has the molecular formula C196H443N31 and a molecular weight of 3234.92 g/mol. Its IUPAC name is 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine.

Molecular Properties

Compound Name2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine
PubChem CID161131089
Molecular FormulaC196H443N31
Molecular Weight3234.92 g/mol
Exact Mass3232.56
IUPAC Name2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine
SMILESC.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.CC(C)N1CCC2(C1)CN(C(C)C)C2.CC(C)N1CCCN(C(C)C)CC1.CC(C)N1CCCN(C(C)C)CCC1.CC(C)N1CCCN(C(C)C)[C@H](C)C1.CC(C)N1CCN(C(C)C)C(C)(C)C1.CC(C)N1CCN(C(C)C)CC1.CC(C)N1CCN(C(C)C)[C@@H](C)C1.CC(C)N1CCN(C(C)C)[C@H](C#N)C1.CC(C)N1CCN(C(C)C)[C@H](C)C1.CC(C)N1CC[C@@H](C)N(C(C)C)CC1.CC(C)N1C[C@@H]2CN(C(C)C)[C@@H]2C1.CC(C)N1C[C@@H]2C[C@H]1CN2C(C)C.CC(C)N1C[C@H]2CC[C@@H](C1)N2C(C)C.CC(C)[C@@H]1CCN(C(C)C)C1.CC(C)[C@H]1CCN(C(C)C)C1.CC[C@@H]1CN(C(C)C)CCN1C(C)C
InChIInChI=1S/2C12H24N2.5C12H26N2.C11H21N3.2C11H22N2.3C11H24N2.C10H22N2.2C10H21N.16CH4/c1-10(2)13-6-5-12(7-13)8-14(9-12)11(3)4;1-9(2)13-7-11-5-6-12(8-13)14(11)10(3)4;1-10(2)13-7-8-14(11(3)4)12(5,6)9-13;1-10(2)13-7-6-12(5)14(9-8-13)11(3)4;1-10(2)13-7-6-8-14(11(3)4)12(5)9-13;1-11(2)13-7-5-9-14(12(3)4)10-6-8-13;1-6-12-9-13(10(2)3)7-8-14(12)11(4)5;1-9(2)13-5-6-14(10(3)4)11(7-12)8-13;1-8(2)12-6-11-5-10(12)7-13(11)9(3)4;1-8(2)12-5-10-6-13(9(3)4)11(10)7-12;2*1-9(2)12-6-7-13(10(3)4)11(5)8-12;1-10(2)12-6-5-7-13(9-8-12)11(3)4;1-9(2)11-5-7-12(8-6-11)10(3)4;2*1-8(2)10-5-6-11(7-10)9(3)4;;;;;;;;;;;;;;;;/h10-11H,5-9H2,1-4H3;9-12H,5-8H2,1-4H3;10-11H,7-9H2,1-6H3;2*10-12H,6-9H2,1-5H3;11-12H,5-10H2,1-4H3;10-12H,6-9H2,1-5H3;9-11H,5-6,8H2,1-4H3;2*8-11H,5-7H2,1-4H3;2*9-11H,6-8H2,1-5H3;10-11H,5-9H2,1-4H3;9-10H,5-8H2,1-4H3;2*8-10H,5-7H2,1-4H3;16*1H4/t;11-,12+;;2*12-;;12-;11-;2*10-,11-;2*11-;;;2*10-;;;;;;;;;;;;;;;;/m...11.110110..10................/s1
InChIKeyUMERUSWJVYOHLH-VRVKEMGDSA-N
XLogP40.83
TPSA120.99 Ų
H-Bond Donors
H-Bond Acceptors31
Rotatable Bonds33
Heavy Atoms227
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003234.92
LogP ≤ 540.83
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1031

Analyze 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine?
The IUPAC name of 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine (CID 161131089) is 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine.
What is the SMILES notation for 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine?
The canonical SMILES for 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine is C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.CC(C)N1CCC2(C1)CN(C(C)C)C2.CC(C)N1CCCN(C(C)C)CC1.CC(C)N1CCCN(C(C)C)CCC1.CC(C)N1CCCN(C(C)C)[C@H](C)C1.CC(C)N1CCN(C(C)C)C(C)(C)C1.CC(C)N1CCN(C(C)C)CC1.CC(C)N1CCN(C(C)C)[C@@H](C)C1.CC(C)N1CCN(C(C)C)[C@H](C#N)C1.CC(C)N1CCN(C(C)C)[C@H](C)C1.CC(C)N1CC[C@@H](C)N(C(C)C)CC1.CC(C)N1C[C@@H]2CN(C(C)C)[C@@H]2C1.CC(C)N1C[C@@H]2C[C@H]1CN2C(C)C.CC(C)N1C[C@H]2CC[C@@H](C1)N2C(C)C.CC(C)[C@@H]1CCN(C(C)C)C1.CC(C)[C@H]1CCN(C(C)C)C1.CC[C@@H]1CN(C(C)C)CCN1C(C)C.
What is the InChIKey of 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine?
The InChIKey is UMERUSWJVYOHLH-VRVKEMGDSA-N. The full InChI is InChI=1S/2C12H24N2.5C12H26N2.C11H21N3.2C11H22N2.3C11H24N2.C10H22N2.2C10H21N.16CH4/c1-10(2)13-6-5-12(7-13)8-14(9-12)11(3)4;1-9(2)13-7-11-5-6-12(8-13)14(11)10(3)4;1-10(2)13-7-8-14(11(3)4)12(5,6)9-13;1-10(2)13-7-6-12(5)14(9-8-13)11(3)4;1-10(2)13-7-6-8-14(11(3)4)12(5)9-13;1-11(2)13-7-5-9-14(12(3)4)10-6-8-13;1-6-12-9-13(10(2)3)7-8-14(12)11(4)5;1-9(2)13-5-6-14(10(3)4)11(7-12)8-13;1-8(2)12-6-11-5-10(12)7-13(11)9(3)4;1-8(2)12-5-10-6-13(9(3)4)11(10)7-12;2*1-9(2)12-6-7-13(10(3)4)11(5)8-12;1-10(2)12-6-5-7-13(9-8-12)11(3)4;1-9(2)11-5-7-12(8-6-11)10(3)4;2*1-8(2)10-5-6-11(7-10)9(3)4;;;;;;;;;;;;;;;;/h10-11H,5-9H2,1-4H3;9-12H,5-8H2,1-4H3;10-11H,7-9H2,1-6H3;2*10-12H,6-9H2,1-5H3;11-12H,5-10H2,1-4H3;10-12H,6-9H2,1-5H3;9-11H,5-6,8H2,1-4H3;2*8-11H,5-7H2,1-4H3;2*9-11H,6-8H2,1-5H3;10-11H,5-9H2,1-4H3;9-10H,5-8H2,1-4H3;2*8-10H,5-7H2,1-4H3;16*1H4/t;11-,12+;;2*12-;;12-;11-;2*10-,11-;2*11-;;;2*10-;;;;;;;;;;;;;;;;/m...11.110110..10................/s1.
What are the key properties of 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine?
2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine has a molecular weight of 3234.92 g/mol, XLogP of 40.83, 33 rotatable bonds, 0 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 2,2-dimethyl-1,4-di(propan-2-yl)piperazine;(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;(1R,5S)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;methane;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;(2S)-2-methyl-1,4-di(propan-2-yl)piperazine is sourced from PubChem (CID 161131089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).